SignalEU/UK

ELI LILLY VS. NOVO NORDISK: ONE HAS 39% UPSIDE. I'M PICKING THE OTHER. - YAHOO

High-profile obesity-drug rivalry with explicit 39% upside forecast drives investor attention.

What changed

High-profile obesity-drug rivalry with explicit 39% upside forecast drives investor attention.

Why it matters

High-profile obesity-drug rivalry with explicit 39% upside forecast drives investor attention. — impact context not separately stored; see What changed.

Sources

yahoo